Abstract:Novel and effective radiosensitizers that can enhance radiosensitivity of tumor tissues and increase the local radiation dose are highly desirable. In this work, templated by bovine serum albumin (BSA), Bi2Se3–MnO2 nanocomposites (Bi2Se3–MnO2@BSA) were fabricated via biomineralization, while Bi2Se3 nanodots act as radiosensitizers to increase the local radiation dosage because of their strong X-ray attenuation ability, and MnO2 with catalase-like activity can increase the oxygen concentration in tumors by triggering the decomposition of tumor endogenous H2O2 so as to improve the hypoxia-associated radioresistance of tumors. Owing to the interaction of the two components in the interface, Bi2Se3–MnO2@BSA showed promoted catalytic activity compared to MnO2@BSA, favoring tumor radiotherapy (RT) sensitization. BSA templating enabled the nanocomposites with high colloidal stability and biocompatibility as well as satisfactory tumor targeting both in vitro and in vivo; thus, an enhanced RT efficacy was obtained. Moreover, the proposed Bi2Se3–MnO2@BSA exhibited excellent performances in computerized tomography and magnetic resonance imaging. Thus, this work provides a tumor microenvironment-responsive multifunctional theranostic nanoagent with an improved performance for imaging-guided tumor RT sensitization.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c05669?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c05669</a>.Magnified TEM image of Bi2Se3–MnO2@BSA; the hydrodynamic particle size of Bi2Se3–MnO2@BSA in PBS, RPMI 1640 medium, and RPMI 1640 medium supplemented with 10% FBS after different incubation times (0, 0.5, 1, 2, and 4 h); colloidal stability of Bi2Se3–MnO2@BSA NPs; XPS spectra of Bi2Se3–MnO2@BSA; characterization of CAT-like activity of MnO2@BSA and Bi2Se3–MnO2@BSA; initial oxygen generation in H2O2 solutions (100 mM) by adding Bi2Se3@BSA, MnO2@BSA, and Bi2Se3–MnO2@BSA NPs at different concentrations; cell apoptosis and necrosis of 4T1 cells after different treatments conducted by flow cytometry analysis; clonogenic SF of 4T1 cells treated with or without Bi2Se3–MnO2@BSA under X-ray at doses of 0, 2, 4, 6, and 8 Gy; hemolysis percentages of Bi2Se3–MnO2@BSA NPs in normal saline at concentrations of 15.6, 31.3, 62.5, 125, 250, and 500 μg mL–1; HE staining of the heart, liver, spleen, lung, and kidney sections dissected from mice on the 13th day post various treatments (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c05669/suppl_file/am1c05669_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Selenium‐doped albumin nanoparticles enhance tamoxifen‐induced anticancer effects in 4T‐1 mouse breast cancer cells

Impact of tamoxifen loaded selenium nanoparticles prepare plasma jet on breast cancer AMJ-13 cell line

Folic acid-conjugated bovine serum albumin-coated selenium-ZIF-8 core/shell nanoparticles for dual target-specific drug delivery in breast cancer

Synthesis and characterization of chitosan–polyvinylpyrrolidone–bovine serum albumin-coated magnetic iron oxide nanoparticles as potential carrier for delivery of tamoxifen

Biocompatible Polymeric Nanoparticles for Effective Codelivery of Tamoxifen with Ganoderic Acid A: Systematic Approach for Improved Breast Cancer Therapeutics

Concept Design, Development and Preliminary Physical and Chemical Characterization of Tamoxifen-Guided-Mesoporous Silica Nanoparticles

Albumin-Templated Bi 2 Se 3 –MnO 2 Nanocomposites with Promoted Catalase-Like Activity for Enhanced Radiotherapy of Cancer

Selenium Tethered Mesoporous Silica Nanocomposite Enhances Drug Delivering Efficiency to Target Breast Cancer

Biocompatible fluorescent carbon nanoparticles as nanocarriers for targeted delivery of tamoxifen for regression of Breast carcinoma

Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells

Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers

Bovine Serum Albumin-Based and Dual-Responsive Targeted Hollow Mesoporous Silica Nanoparticles for Breast Cancer Therapy

Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer

Improving Tamoxifen Performance in Inducing Apoptosis and Hepatoprotection by Loading on a Dual Nanomagnetic Targeting System

The creation of selenium nanoparticles decorated with troxerutin and their ability to adapt to the tumour microenvironment have therapeutic implications for triple-negative breast cancer

Enhanced docetaxel therapeutic effect using dual targeted SRL-2 and TA1 aptamer conjugated micelles in inhibition Balb/c mice breast cancer model

Albumin-Templated Bi2Se3-MnO2 Nanocomposites with Promoted Catalase-Like Activity for Enhanced Radiotherapy of Cancer.

Rational Design of Cancer-Targeted BSA Protein Nanoparticles As Radiosensitizer to Overcome Cancer Radioresistance

Boosting Natural Killer Cell-Based Cancer Immunotherapy with Selenocystine/Transforming Growth Factor-Beta Inhibitor-Encapsulated Nanoemulsion

Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice

N-acetyl-d-glucosamine decorated solid lipid nanoparticles for targeted tamoxifen delivery to breast cancer cells